SG42791A1 - 2-hydroxy-3-[1h-imidazol-4-yl)alkyl]-benzenecarboximidamides - Google Patents

2-hydroxy-3-[1h-imidazol-4-yl)alkyl]-benzenecarboximidamides

Info

Publication number
SG42791A1
SG42791A1 SG1995001717A SG1995001717A SG42791A1 SG 42791 A1 SG42791 A1 SG 42791A1 SG 1995001717 A SG1995001717 A SG 1995001717A SG 1995001717 A SG1995001717 A SG 1995001717A SG 42791 A1 SG42791 A1 SG 42791A1
Authority
SG
Singapore
Prior art keywords
alkyl
benzenecarboximidamides
imidazol
hydroxy
hydrogen
Prior art date
Application number
SG1995001717A
Other languages
English (en)
Inventor
Philippe Michel
Eric Cossement
Jean Gobert
Ernst Wulfert
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of SG42791A1 publication Critical patent/SG42791A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1995001717A 1993-05-27 1994-05-19 2-hydroxy-3-[1h-imidazol-4-yl)alkyl]-benzenecarboximidamides SG42791A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310965A GB9310965D0 (en) 1993-05-27 1993-05-27 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides

Publications (1)

Publication Number Publication Date
SG42791A1 true SG42791A1 (en) 1997-10-17

Family

ID=10736226

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995001717A SG42791A1 (en) 1993-05-27 1994-05-19 2-hydroxy-3-[1h-imidazol-4-yl)alkyl]-benzenecarboximidamides

Country Status (21)

Country Link
US (1) US5385927A (https=)
EP (1) EP0626372B1 (https=)
JP (1) JPH0770082A (https=)
AT (1) ATE198196T1 (https=)
AU (1) AU673422B2 (https=)
CA (1) CA2124289A1 (https=)
CZ (1) CZ287136B6 (https=)
DE (1) DE69426433D1 (https=)
FI (1) FI942390L (https=)
GB (1) GB9310965D0 (https=)
HU (1) HUT67813A (https=)
IL (1) IL109750A (https=)
MY (1) MY111216A (https=)
NO (1) NO303824B1 (https=)
NZ (1) NZ260588A (https=)
PL (1) PL175970B1 (https=)
RU (1) RU2125557C1 (https=)
SG (1) SG42791A1 (https=)
SK (1) SK60394A3 (https=)
TW (1) TW263500B (https=)
ZA (1) ZA943651B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
CA2258915A1 (en) * 1996-06-25 1997-12-31 Michael Robert Wiley Anticoagulant agents
PL360707A1 (en) * 2000-07-14 2004-09-20 Allergan Inc. Compositions containing alpha-2-adrenergic agonist components
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
EP2196461A1 (de) 2008-12-15 2010-06-16 Bayer CropScience AG 4-Amino-1,2,3-benzoxathiazin-Derivate als Pestizide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
FI98815C (fi) * 1990-11-30 1997-08-25 Santen Oy Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi

Also Published As

Publication number Publication date
HUT67813A (en) 1995-05-29
TW263500B (https=) 1995-11-21
PL175970B1 (pl) 1999-03-31
ZA943651B (en) 1995-01-26
US5385927A (en) 1995-01-31
RU2125557C1 (ru) 1999-01-27
EP0626372B1 (fr) 2000-12-20
MY111216A (en) 1999-09-30
NO941932D0 (no) 1994-05-25
CZ287136B6 (en) 2000-09-13
JPH0770082A (ja) 1995-03-14
IL109750A0 (en) 1994-08-26
NO941932L (no) 1994-11-28
DE69426433D1 (de) 2001-01-25
CA2124289A1 (en) 1994-11-28
NO303824B1 (no) 1998-09-07
AU6330394A (en) 1994-12-01
FI942390A7 (fi) 1994-11-28
EP0626372A1 (fr) 1994-11-30
IL109750A (en) 1998-06-15
FI942390L (fi) 1994-11-28
NZ260588A (en) 1995-09-26
AU673422B2 (en) 1996-11-07
CZ124794A3 (en) 1994-12-15
FI942390A0 (fi) 1994-05-24
SK60394A3 (en) 1995-07-11
ATE198196T1 (de) 2001-01-15
HU9401574D0 (en) 1994-08-29
GB9310965D0 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
EP0437030A3 (en) Use of 4-substituted imidazoles for lowering intraocular pressure
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
AU557094B2 (en) 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5,5)undecan 3-ones
AU3582095A (en) Isothiourea derivatives as no synthase inhibitors
TW263500B (https=)
WO1999003817A3 (en) Aliphatic propargylamines as cellular rescue agents
GB2115815B (en) Benzothiazoline compounds
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
AU7509481A (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ZA901981B (en) Thienylacetic acid derivatives,process for the preparation thereof,the use thereof,and pharmaceuticals containing these and the preparation thereof
AU579997B2 (en) Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use